Table 1 Clinical and demographic characteristics of women with MS included in the study (n = 137)

Age (years), X (SD)

38.3 (7.2)

Disease duration (years), X (SD)

8.3 (6.0)

History of childbirth, n (%)

52 (49.1)

Stable partner, n (%)

91 (75.2)

Professional status: active, n (%)

94 (75.2)

EDSS (median, p25 – p75)

2 (1–2.5)

 - EDSS < 3, n (%)

115 (83.9)

 - EDSS ≥3, n (%)

22 (16.1)

Patients on DMT

 - No treatment

20 (14.6)

 - First line, n (%)

38 (27.7)

 - heDMT, n (%)

79 (57.7)

Myelitis, n (%)

85 (62.5)

 - Cervical, n (%)

41 (53.9)

 - Dorsal, n (%)

9 (11.8)

 - >  1 level, n (%)

26 (34.2)

 - Diffuse, n (%)

0

Sphincter symptoms, n (%)

53 (38.7)

Referred fatigue, n (%)

51 (37.8)

MFIS (n = 58), X (SD)

20.4 (18.3)

Depression on specific treatment

18 (13.2)

BDI-II (n = 54), X (SD)

23.5 (19.6)

Women on CNS depressants, n (%)

32 (23.5)